Recent Updates
Recently added Catalysts
ORIC Positive Sentiment

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Monday, March 6, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ORIC Pharmaceuticals, a clinical-stage oncology firm, announced that its management will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at 2:00 p.m. ET. This event aims to boost the company’s visibility in the healthcare sector. Investors can access the live webcast through the company's website, with replays available for 90 days following the event.
Price reaction · baseline $4.51 (2023-03-03 close) · clean, no other ORIC news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is actively participating in a prominent healthcare conference.
  • Management engagement in industry events enhances company visibility.
  • The opportunity for live webcasts provides transparency and accessibility for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+58%
120-day peak, hindsight
Typical move
10.1%
average across 6 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
ORIC-944
Phase 1 · Metastatic Prostate Cancer

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) --  ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, at 2:00 p.m. ET.
The live webcast of the discussion will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.

Frequently Asked Questions

When is ORIC Pharmaceuticals participating in the Oppenheimer Conference?

ORIC Pharmaceuticals will participate on March 13, 2023, at 2:00 p.m. ET.

Where can I watch the ORIC Pharmaceuticals webcast?

The webcast will be available on the investor section of ORIC's website.

How long will the webcast replay be available?

Replays of the webcasts will be available for 90 days after the event.

Who is the Chief Financial Officer of ORIC Pharmaceuticals?

Dominic Piscitelli is the Chief Financial Officer of ORIC Pharmaceuticals.

ShareAdd on Google
Tags: ORIC Viatris Investor Conferences Healthcare healthcare conference oncology Oppenheimer investor relations
Last updated: Mar 6, 2023

Biotech snapshot

Cash runway
$388M liquidity · $11M/mo burn
~36 mo
Minimal dilution risk
Lead asset
ORIC-944Phase 1
Metastatic Prostate Cancer →

Catalyst track record

+58%
best trade around ORIC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ORIC.

See every catalyst's timing & PoA →